Кардиомиопатия у кошек: литература
Atkins СЕ, Gallo AM, Kurzman ID, et al: Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc 201:613, 1992. Retrospective study describing clinical signs and prognosis in 74 cats with hypertrophic cardiomyopathy.
Bonagura JB, Fox PR: Restrictive cardiomyopathy. In: BonaguraJB, ed: Kirk's Current Veterinary Therapy XII: Small Animal Practice. Philadelphia: WB Saunders, 1995, p 863. A clinical presentation proposing pathophysiology and suggested therapy for feline restrictive cardiomyopathy.
Bright JM, Golden AL, Gompf RE, et al: Evaluation of the calcium channel-blocking agents diltiazeni and verapamil for treatment of feline hypertrophic cardiomyopathy. J Vet Intern Med 5:272, 1991. Prospective study evaluating the clinical effects of diltiazem, verapamil, and propranolol on clinical outcome in cats with idiopathic hypertrophic cardiomyopathy.
Fox PR: Feline myocardial disease. In: Fox PR, ed: Canine and Feline Cardiology. New York: Churchill Livingstone, 1988, p 435. A description of feline myocardial diseases, including etiology, pathophysiology, clinical diagnosis, and therapy.
Fox PR, Liu SK, Maron B: Echocardiography assessment of spontaneously occurring feline hypertrophic cardiomyopathy: An animal model of human disease. Circulation 92:2645, 1995. A prospective study recording the phenotypic characterization, gross pathology and microscopic findings, and clinical outcome of 47 cats with idiopathic hypertrophic cardiomyopathy.
Keene BW, Rush JE: Therapy of heart failure. In: Ettinger SJ, Feldman EC, eds: Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, 4th ed. Philadelphia: WB Saunders, 1995, p 867. A summary and update of drug indications for, use of, and overall strategies for managing congestive heart failure in the dog and cat.
Quinones M, Dyer DC, Ware WA, et al: Pharmacokinetics of atenolol in clinically normal cats. Am J Vet Res 57:1050, 1996. Study to determine the pharmacokinetics of atenolol given intravenously and orally in nine clinically normal cats.
Sharpe N: Beta-blockers in heart failure. Heart Failure Rev 1:5,1996. Rationale for the use of beta blockade in heart failure, including neurohumoral alterations and clinical trials are reviewed.
Sisson DD, Thomas WP: Myocardial diseases. In: Ettinger SJ, Feldman EC, eds: Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, 4th ed. Philadelphia: WB Saunders, 1995, p 995. A review of the causes of pathophysiology of, and therapies for canine and feline cardiomyopathies.
Spirito P, Seidman CE, McKenna WJ, et al: The management of hypertrophic cardiomyopathy. N Engl J Med 336:775, 1997. A review of clinical presentations of hypertrophic cardiomyopathy in humans and corresponding treatment strategies.
